Recently, the "Maidong Technology Park", which is the global headquarters base of Mindray Animal Medical, officially started construction in Longhua, Shenzhen.

It is reported that the land for the Maidong Technology Park project will be sold in September 2023, covering an area of 58600 square meters and a building area of 176000 square meters. The total planned investment is 1.774 billion yuan. After completion, it will create an intelligent manufacturing "black light" factory with high-precision automation equipment covering the entire area. Through automatic and intelligent on-site logistics scheduling, efficient, high-quality, and low-cost manufacturing will be achieved.

01. Expected annual output value exceeds 12 billion
In recent years, Mindray Medical has begun to focus on four emerging businesses, namely animal medicine, minimally invasive surgery, orthopedics, and AED, on the basis of its traditional three core businesses. In 2022, Li Xiting, Chairman of Mindray Medical, made a statement Animal medicine is a very important branch for the future development of Mindray.

In October 2020, Mindray Medical invested 200 million yuan to establish Shenzhen Mindray Animal Medical Technology Co., Ltd., announcing its full commitment to pet healthcare. As a high potential business that Mindray is cultivating, Mindray's animal medical product line spans across three major fields: medical imaging, in vitro diagnostics, and life information and support. It is a horizontal expansion of the company's traditional three core businesses and is suitable for multiple scenarios such as pet hospitals, livestock farms, horse farms, wild or rare animal protection, and scientific research.

The Maidong Science and Technology Park, which is under construction this time, is located in the Jiulongshan Advanced Manufacturing Industrial Park. It is understood that as the new global headquarters base of Mindray Animal Medical, Maidong Science and Technology Park will be built into a world-class comprehensive animal medical technology park. While carrying the global research and development center, global user service center, and global academic exchange center, its intelligent manufacturing production base will cover the production of animal specific life information and support, medical imaging and in vitro diagnosis equipment, reagents, and consumables. The construction of a fully automated digital logistics base will also provide strong support for the vigorous development of Maidong Science and Technology Park.

According to previous reports, the project is expected to generate an average annual output value of over 12 billion yuan and a tax revenue of over 600 million yuan after completion.

02. Located in a world-class medical equipment industry cluster
The Longhua District International Medical Equipment City Industrial Zone, where Maidong Technology Park is located, is a world-class medical equipment industry cluster that has been vigorously developed in Shenzhen in recent years.

According to the Action Plan for Cultivating and Developing High end Medical Device Industry Clusters in Shenzhen (2022-2025), Longhua is vigorously developing the high-end medical device industry, with Shenzhen International Medical Device City as the core driving engine, striving to build a "one city, five parks" high-end medical device industry development spatial layout, and creating a world-class high-end medical device industry cluster with high standards.

Mindray Medical has twice acquired land in this area. In addition to the land used for the construction of the Mindray Technology Park, the construction of Mindray Medical's global supply chain headquarters, Longhua Technology Industrial Park, officially began in June 2022.

It is reported that the total investment of Mindray Medical Longhua Base project is 2.2 billion yuan, which will build a manufacturing base for medical devices, in vitro diagnostic reagents, and a series of supporting facilities to promote Mindray Medical's comprehensive upgrading of its global supply chain layout and create the group's global supply chain headquarters. It is expected that by 2030, the Mindray Longhua Base will carry more than 60% of the group's supply chain capacity, and in conjunction with the Mindray Medical Shenzhen Bright Base, will form a dual wheel drive pattern, leading the total output value of Mindray Medical's Shenzhen manufacturing sector to exceed the target of 100 billion yuan by 2030.

In addition to Mindray Medical, top enterprises and specialized new enterprises such as Guochuang Center, Security Technology, Beixin Life, and silicon-based bionic have all landed.

According to the planned goals issued by Shenzhen, by 2025, the added value of the city's high-end medical device industry will reach 65 billion yuan, and the operating revenue will reach 200 billion yuan. Attract world-renowned medical device companies to establish more than 5 production bases, regional headquarters, or R&D headquarters in Shenzhen, forming a 100 billion level professional manufacturing park.

03. Super fast speed with medical equipment, a blue ocean track full of imagination
According to estimates, the global pet medical device market will reach approximately 7 billion US dollars in 2021, mainly concentrated in Europe and America. China is the world's second-largest pet market. According to the 2022 White Paper on China's Pet Healthcare Industry, the number of urban dogs and cats in China reached 117 million in 2022, a year-on-year increase of 8.7%. In 2022, the number of pet diagnosis and treatment institutions in China reached 19930, and the pet medical market size was about 67.5 billion yuan, showing a continuous upward trend.

The pet medical industry in China is booming, with core equipment widely popularized and significantly improved diagnostic and treatment levels. Market research reveals that there are over 20000 pet hospitals in China, of which nearly 44% are newly built in the past three years, with the contribution of domestically produced equipment being particularly significant.

According to authoritative institutions such as the National Veterinary Medicine Industry Technology Innovation Alliance and the China Veterinary Medicine Association, the market share of domestic pet medical equipment brands has slightly surpassed that of foreign brands, and imaging equipment continues to dominate the market.

Incomplete statistics show that the number of pet medical equipment and device related enterprises in China has exceeded 450. Companies such as Mindray Medical, Lepu Medical, and Neusoft Medical have all ventured into the field of pet medicine, successfully applying the technological innovation and research and development experience of human medical equipment to animal medicine, effectively promoting the rapid development of the domestic pet medical equipment industry.

In 2021, Lepu Medical established a new animal medical business division, relying on its profound medical device business background and leading artificial intelligence ECG analysis and diagnosis technology, through unremitting research and innovation, skillfully integrating its diversified product lines and technology essence. The business unit has carefully constructed five core product lines covering surgical procedures, vital sign monitoring, in vitro diagnostics, imaging equipment, and interventional equipment, bringing rich and diverse application scenarios and personalized health care services to pet hospitals and pet families, comprehensively safeguarding pet health.

In June 2019, Neusoft Medical and Ruipai Pet Hospital Management Co., Ltd. jointly established the "Pet Imaging Specialist Training Conference and Imaging Clinical Research Base". In September 2022, Neusoft Medical launched three pet imaging diagnosis and treatment devices and a remote medical platform, marking the beginning of Neusoft Medical's efforts in the animal diagnosis and treatment market.

Source: http://qixieke.com/Font/index/detailPage.html?id=3229-19